4Pcng YL, Leu HB, Luo JC, et al. Diabetes is an independent risk factor for peptic ulcer bleeding: a nationwide population - based cohort study [J]. J Gastroenterol Hepatol, 2013, 28 (8) : 1295 -1299.
5Tscng PH, Lee YC, Chiu HM, et al. Association of diabetes and HbAlc levels with gastrointestinal manifestations [ J ]. Diabetes Care, 2012, 35 (5): 1053-1060.
6Klebl FH, Bregenzer N, Scht:fer L, et al. Comparison of inpatient and outpatient upper gastrointestinal haemorrhage [ J]. Int J Coloree- tal Dis, 2005, 20 (4): 368-375.
7Sehimke K, Chubb SA, Davis WA, et al. Antiplatelet therapy, He- lieobaeter pylori infection and complicated peptic ulcer disease in diabe- tes : the Fremantle Diabetes Study [ J ]. Diabetic Medicine, 2009, 26 (1): 70-75.
8Fau]k CE, Sandoval A, Draughon M, et al. Critical gastrointestinal bleeding at an inpatient rehabilitation center: incidence, risk factors, and the role of gastrointestinal prophylaxis [ J ]. Am J Pharmacog- enomics, 2010, 2 (12) : 1104-1112.
9Thomsen RW, Riis A, Christensen S, et al. Diabetes and 30 - day mortality from peptic ulcer bleeding and perforaxion a danish population - based cohort study [J] Diabetes Care, 2006, 29 (4) : 805 - 810.
10Leontiadis GI, Molloy - Bland M, Moayyedi P, et al. Effect of co- morbidity on mortality in patients with peptic ulcer bleeding: systematic review :d meta- analysis [ J ]. Am J Gastroenterol, 2013, 108 (3) : 331 -345.
